ConnectiveRx Acquires Rx Savings Assistant from Medicom Digital

RedSail Technologies Acquires PrimeRx

February 12, 2026

Healthcare Services

RedSail Technologies acquired PrimeRx as an affiliate, expanding its pharmacy software and data network to approximately 16,000 pharmacies across the United States. PrimeRx will continue operating under its existing brand while integrating with RedSail’s broader suite of connected solutions such as RedSail Pay, RxCash+ and RxMile.

MedImpact Acquires Sav-Rx

February 2, 2026

Healthcare Services

MedImpact Healthcare Systems has completed the acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The deal expands MedImpact's scale, specialized PBM expertise, and health solutions portfolio while allowing Sav-Rx to operate independently under its existing leadership.

Medvantx Acquires RxS

July 8, 2025

Healthcare Services

Medvantx, a San Diego-based pharmacy services provider, has acquired RxS, a multichannel sample management and accountability solutions company headquartered in Manalapan, New Jersey. The acquisition integrates RxS’s sampling and engagement technology with Medvantx’s patient access, PAP fulfillment, telehealth and distribution services to broaden capability and accelerate access for pharmaceutical and device manufacturers.

Custom Health Acquires PatchRx

January 1, 2024

Healthcare Services

Custom Health has acquired PatchRx, integrating PatchRx’s patented PatchCap smart pill-bottle cap technology and team into Custom Health’s AdhereNet platform to expand connected medication monitoring. The acquisition brings PatchRx’s device and adherence software capabilities into Custom Health’s medication management offering, strengthening monitoring for pain management and opioid safety.

McKesson Signs Agreement to Acquire Rx Savings Solutions

September 19, 2022

Healthcare Services

McKesson Corporation has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company focused on affordability and medication adherence for health plans and large self-funded employers. The transaction is valued up to $875 million ($600 million upfront plus up to $275 million contingent on RxSS performance through calendar year 2025) and is expected to close in the second half of fiscal 2023, subject to customary regulatory approvals. Following closing, RxSS will become part of McKesson’s Prescription Technology Solutions business.

OptimizeRx Acquires EvinceMed Specialty Drug Market Access Platform

March 15, 2022

Healthcare Services

OptimizeRx Corporation acquired the EvinceMed platform and related assets to integrate end-to-end automation for specialty pharmaceutical transactions into its point-of-care network. The purchase expands OptimizeRx’s capabilities for specialty drug prescribing, patient enrollment into manufacturer support programs, and point-of-dispense connectivity to improve patient access and accelerate time-to-therapy.